Applied Dna Sciences Inc (NASDAQ:BNBX – Get Free Report) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totaling 55,360 shares, a drop of 60.5% from the May 31st total of 140,122 shares. Currently, 0.8% of the company’s shares are short sold. Based on an average daily trading volume, of 236,645 shares, the days-to-cover ratio is currently 0.2 days.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Applied Dna Sciences in a research report on Friday, April 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of “Sell”.
Read Our Latest Analysis on BNBX
Applied Dna Sciences Stock Down 4.4%
Applied Dna Sciences (NASDAQ:BNBX – Get Free Report) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.68) earnings per share for the quarter. The firm had revenue of $1.02 million for the quarter. Applied Dna Sciences had a negative return on equity of 349.95% and a negative net margin of 1,647.25%.
About Applied Dna Sciences
Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.
Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.
Featured Articles
- Five stocks we like better than Applied Dna Sciences
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Applied Dna Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Dna Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
